Outcomes of Optic Nerve Sheath Decompression for Visual Loss in Idiopathic Intracranial Hypertension
|Nada Jirasková1,4, Pavel Rozsíval1,4, Alexander Stepanov1,4, Vera Velika1,4and Jan Lešták2,3,4*|
|1Department of Ophthalmology, University Hospital and Charles Medical Faculty, Hradec Králové, Czech Republic|
|2JL Clinic, V Hurkách 1296/10, Prague, Czech Republic|
|3Faculty of Biomedical Engineering, Czech Technical University in Prague, Czech Republic|
|4Faculty of Medicine in Hradec Kralove, Charles University, Czech Republic|
|Corresponding Author :||Jan Lešták, MD, PhD, FEBO
JL Clinic, V Hurkách 1296/10, Prague, Czech Republic
E-mail: [email protected]
|Received February 12, 2013; Accepted March 29, 2013; Published April 04, 2013|
|Citation: Jirasková N, Rozsíval P, Stepanov A, Velika V, Lešták J (2013) Outcomes of Optic Nerve Sheath Decompression for Visual Loss in Idiopathic Intracranial Hypertension. J Clin Exp Ophthalmol S3:006. doi:10.4172/2155-9570.S3-006|
|Copyright: © 2013 Jirasková N, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.|
|Related article at
Pubmed Scholar Google
Purpose: To report our experience with optic nerve sheath decompression (ONSD) for visual loss in idiopathic intracranial hypertension (IIH).
Methods: Six patients (7 eyes) with idiopathic intracranial hypertension and visual loss were involved. Five women and 1 man (mean age 42 years, ranged from 12 to 65 years) were operated at the Department of Ophthalmology, University Hospital, Hradec Králové. Surgeries were performed by a standard medial transconjunctival approach and the sheaths were cut by three incisions. We have not seen any serious intra and postoperative complications. Only one patient developed transient double vision after surgery.
Results: Visual functions improved in 5 patients. In one patient permanent visual loss with optic atrophy in both eyes occurred due to long-term duration of papilledema before referral to us.
Conclusions: On the basis of our results, we believe that ONSD is safe and effective treatment of patients with IIH in vision-threatening cases after thoroughly balanced assessment of possible risks and gains.